Hard for bulls to win on a morning like today and hard for bears as well, just a tricky day of price action for Wall Street. Biotech stocks somehow manage to not get affected with this Iran crisis. Biotech Catalyst Swing Names that look primed for a rally:
Jounce Therapeutics (JNCE)
Catalyst Dates: New Phase 1/2 cancer dated to be presented on February 6th
Rockwell Medical (RMTI)
Catalyst Dates: FDA Approval date of March 28th
Correvio Pharma (CORV)
Catalyst Dates: FDA Approval Date of April 27th with partner UTHR
22nd Century Group (XXII)
Catalyst Dates: Advisory Panel on February 14th
Dynavax (DVAX)
Catalyst Dates: Possible european CHMP decision coming in January
Lannett Company (LCI)
Catalyst Dates: Possible FDA approval coming Early 2020